Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Elan’s Saga Comes To A Close With Perrigo’s $8.6 Billion Bid

Aug 05 2013

• By Lisa LaMotta

Related Content

It's Fusion As Jazz Pharmaceuticals, Azur Pharma Reach Merger Agreement

Sep 20 2011

Elan Unit’s Acquisition Brings Diversification, Cash Flow, To Alkermes

May 16 2011

Regional Firms Must Compete With Multinationals At Home And Away

May 14 2012

Tax Benefits Highlight Announced Merger Of Valeant And Biovail

Jun 21 2010

Elan’s Martin Aims To Set The Record Straight About Recent Buying Spree

Jun 07 2013

Tax Benefits, Branded Portfolio, Synergies Drive Actavis’ Acquisition of Warner Chilcott

May 27 2013

Related Companies

Perrigo Company PLC

Elan Corporation

Royalty Pharma plc

Bausch Health Companies Inc.

Jazz Pharmaceuticals plc

Alkermes plc

Allergan plc

Jazz Pharmaceuticals plc

Alkermes plc

Bausch Health Companies Inc.

Biogen, Inc.

Additional Topics

Strategy Business Strategies Deals OTC Drugs BioPharmaceutical Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window